Explore more about: Point of Care

Due to its high accuracy, lab-based PCR testing is the gold standard for infectious disease diagnostics. Yet PCR's availability is limited, especially in low-resource settings. New research suggests a new kind of test could be more streamlined without sacrificing performance.

In recognition of International Women’s Day (March 8), we’re featuring Rebecca Richards-Kortum, Ph.D., a longtime bioengineer in academia who has contributed globally to improving women's health.

NIH announced finalists in its competition to accelerate development of diagnostic and monitoring technologies to improve fetal health outcomes in low-resource settings.

A new RADx Tech fellowship aims to increase diversity among biotechnology innovators. Fellows who recently completed the six-month program share their perspectives on how the fellowship helped them advance their technologies.

NIH will advance the development of home-based and point-of-care health technologies with awards to six technology research and development centers around the country. The centers comprise the Point of Care Technology Research Network (POCTRN) and will parlay the momentum of the original network established in 2007 by the NIBIB.

Now in its 12th year, the DEBUT Challenge calls on teams of undergraduate students to produce technological solutions to a broad spectrum of unmet health needs.

New recommendations from the NIH Rapid Acceleration of Diagnostics (RADx®) Tech Program provide a blueprint for the design and manufacture of more accessible diagnostic tests.

One day, the ultrasound equipment that health care professionals use for essential diagnostic imaging may no longer be confined to the clinic, instead operated by patients in the comfort of their homes. New research marks a major step toward that future.

A research team funded by the National Institutes of Health has shown that commercially available rapid antigen tests can detect past and present variants of concern and has identified potential mutations that may impact test performance in the future.

Scientists have developed a single point-of-care assay that identifies malaria, typhoid—or both simultaneously—in just 15 minutes.